Stockreport

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering RAVICTI® (glycerol phenylbutyrate) Oral Liquid

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report
PDF - Will Represent the Eighth and Ninth U.S. Patents to be Listed in the Orange Book for RAVICTI - DUBLIN, Ireland, May 08, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma pl [Read more]